NCT05947227

Brief Summary

Group A will be treated with manual chest physical therapy and Buteyko breathing technique Group-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique. Patients will perform the technique 5 times a weeks for 8weeks and treatment evaluation will be done after 8 weeks

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

June 15, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 17, 2023

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2023

Completed
Last Updated

June 13, 2024

Status Verified

June 1, 2024

Enrollment Period

2 months

First QC Date

June 14, 2023

Last Update Submit

June 11, 2024

Conditions

Keywords

Chronic obstructive pulmonary disease/COPDDiaphragmatic breathing technique

Outcome Measures

Primary Outcomes (1)

  • 6 Minute Walk Distance

    Distance will be measured in meter through 6 minute walk test.

    4 weeks.

Secondary Outcomes (1)

  • St George Respiratory Questionnaire for quality of life :

    4 weeks.

Other Outcomes (2)

  • oxygen saturation

    4 weeks

  • heart rate

    4 weeks

Study Arms (2)

manual chest physical therapy and Buteyko breathing technique

EXPERIMENTAL

Group A will be treated with manual chest physical therapy and Buteyko breathing technique

Other: Buteyko breathing technique

manual chest physical therapy and Diaphragmatic breathing technique.

EXPERIMENTAL

Group-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique.

Other: Diaphragmatic breathing technique.

Interventions

Group A : will be treated with manual chest physiotherapy \& Buteyko Breathing exercise

manual chest physical therapy and Buteyko breathing technique

Group B : will be treated with manual chest physiotherapy \& Diaphragmatic Breathing Treatment evaluation will be done after 8 weeks through 6MWT \& St George respiratory Questionnaire. Patients will perform technique 5 times a weeks for 8 weeks

manual chest physical therapy and Diaphragmatic breathing technique.

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age group : 40-65 years
  • Both males and females
  • Clinical diagnosis of COPD confirmed by smoking history and PFT airflow
  • Patients taking their regular medications e.g bronchodilator

You may not qualify if:

  • Restrictive lung disease
  • Pneumothorax
  • Resting O2 saturation \<90% with room air breathing
  • Recent exacerbations
  • Patients with active viral or bacterial infection
  • Abdominal or thoracic surgery (\<3months ago)
  • Cardiologic conditions (\<6months ago e.g Myocardial infarction or unstable angina
  • Intubated Patients
  • Orthopedic or urogenital conditions
  • Neurological disorders limiting cognition \& mobility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gulab Devi Hospital, Lahore

Lahore, Punjab Province, Pakistan

Location

Related Publications (7)

  • Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review. Int J Chron Obstruct Pulmon Dis. 2020 Feb 26;15:439-460. doi: 10.2147/COPD.S234942. eCollection 2020.

    PMID: 32161455BACKGROUND
  • Chatreewatanakul B, Othaganont P, Hickman RL. Early symptom recognition and symptom management among exacerbation COPD patients: A qualitative study. Appl Nurs Res. 2022 Feb;63:151522. doi: 10.1016/j.apnr.2021.151522. Epub 2021 Nov 6.

    PMID: 35034709BACKGROUND
  • Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I; NIHR RESPIRE Global Respiratory Health Unit. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Respir Med. 2022 May;10(5):447-458. doi: 10.1016/S2213-2600(21)00511-7. Epub 2022 Mar 10.

    PMID: 35279265BACKGROUND
  • Gea J, Agusti A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985). 2013 May;114(9):1222-34. doi: 10.1152/japplphysiol.00981.2012. Epub 2013 Mar 21.

    PMID: 23519228BACKGROUND
  • Cavalcanti JD, Fregonezi GAF, Sarmento AJ, Bezerra T, Gualdi LP, Pennati F, Aliverti A, Resqueti VR. Electrical activity and fatigue of respiratory and locomotor muscles in obstructive respiratory diseases during field walking test. PLoS One. 2022 Apr 1;17(4):e0266365. doi: 10.1371/journal.pone.0266365. eCollection 2022.

    PMID: 35363800BACKGROUND
  • Tang CY, Taylor NF, Blackstock FC. Chest physiotherapy for patients admitted to hospital with an acute exacerbation of chronic obstructive pulmonary disease (COPD): a systematic review. Physiotherapy. 2010 Mar;96(1):1-13. doi: 10.1016/j.physio.2009.06.008. Epub 2009 Sep 22.

    PMID: 20113757BACKGROUND
  • Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, Lopez Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agusti A. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.

    PMID: 28128970BACKGROUND

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sidra Faisal, MS.CPPT

    Riphah International University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group A will be treated with manual chest physical therapy and Buteyko breathing technique Group-B will be treated with manual chest physical therapy and Diaphragmatic breathing technique. Patients will perform the technique 5 times a weeks for 8weeks and treatment evaluation will be done after 8 weeks.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 14, 2023

First Posted

July 17, 2023

Study Start

June 15, 2023

Primary Completion

August 15, 2023

Study Completion

November 20, 2023

Last Updated

June 13, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

Locations